South San Francisco, CA, United States of America

Andrew I McDonald

USPTO Granted Patents = 14 

Average Co-Inventor Count = 9.2

ph-index = 4

Forward Citations = 102(Granted Patents)


Location History:

  • San Francisco, CA (US) (2005 - 2014)
  • South San Francisco, CA (US) (2009 - 2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew I McDonald

Introduction

Andrew I McDonald is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of anti-cancer research, holding a total of 14 patents. His work focuses on developing compounds that target cellular proliferative diseases, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest patents are groundbreaking innovations such as imidazole-benzamide anti-cancer agents. These compounds are designed to treat cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins. Additionally, he has developed compounds, compositions, and methods that are useful for treating similar diseases by modulating the activity of KSP.

Career Highlights

Throughout his career, Andrew has worked with notable companies, including Cytokinetics, Inc. and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in cancer treatment.

Collaborations

Andrew has collaborated with esteemed colleagues such as Gustave Bergnes and David John Morgans, Jr. These partnerships have further enriched his research and development efforts in the field of anti-cancer agents.

Conclusion

Andrew I McDonald stands out as a dedicated inventor whose work has the potential to impact the treatment of cancer significantly. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…